Aimmune Therapeutics, Inc.

Q1 2016 13F Holders

Symbol
AIMT
CUSIP
00900T107
Type
Equity
Class
COM
Num filings
71
Total reported value, excl. options
$374 M
Manager Report Date Value ($000) Shares Option Type